Here's how to tell if your heart is trending towards accelerated aging—and what to do if it is, according to an expert cardiologist.
Background The National Heart Failure Audit gathers data on patients coded at discharge (or death) as having heart failure as ...
The epidemiology of hypertension in India has undergone a malignant shift, moving from a disease of the elderly to a ...
Rakuten Medical, Inc., a global biotechnology company developing and commercializing its proprietary Alluminox® platform-based photoimmunotherapy, today announced the closing of a $100 million Series ...
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company," 6990.HK) today announced that its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, al ...
1) Innovent has positioned itself at the forefront of China’s GLP-1 market with Mazdutide, the first-in-class dual GCG/GLP-1 receptor agonist approved for obesity and overweight in June 2025.
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...